Can ramipril cause hyponatremia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 1, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Can Ramipril Cause Hyponatremia?

Yes, ramipril can cause hyponatremia, though this is an uncommon adverse effect. The FDA drug label explicitly lists hyponatremia as a documented adverse reaction, and case reports confirm this association, particularly when ramipril is combined with diuretics 1.

Mechanism and Clinical Evidence

Ramipril, as an ACE inhibitor, can induce hyponatremia through the syndrome of inappropriate antidiuretic hormone secretion (SIADH). The FDA label documents scattered incidents of hyponatremia in clinical trials, though the exact incidence is not specified 1.

The risk is substantially higher when ramipril is combined with thiazide diuretics, which are themselves the leading cause of drug-induced hyponatremia 1, 2. A case report documented severe, life-threatening hyponatremia (sodium dropping to 112 mmol/L) in a patient on ramipril that resolved only after discontinuation of the medication 3. Another case showed a patient on both bendroflumethiazide and ramipril who developed severe hyponatremia (120 mmol/L) with seizures and asystole 4.

Key Clinical Considerations

When to Suspect Ramipril-Induced Hyponatremia:

  • Timing: Most drug-induced hyponatremia occurs shortly after medication initiation, though it can develop at any time 2, 5
  • Combination therapy: Particularly high risk when ramipril is used with thiazide diuretics 1, 4
  • Clinical presentation: Look for confusion, weakness, paraesthesiae, seizures, or altered mental status 4

Monitoring Requirements:

Check a basic metabolic panel 2-4 weeks after initiating or titrating ramipril dose 6. This is a Grade A recommendation from current hypertension guidelines. The FDA label specifically warns about hyponatremia and recommends monitoring electrolytes, particularly when ramipril is combined with diuretics 1.

Management Algorithm:

  1. If hyponatremia is detected: Discontinue ramipril immediately 3
  2. Do not rechallenge: Once ramipril-induced hyponatremia is confirmed, avoid restarting the medication, as recurrence is likely 3
  3. Rule out other causes: Check thyroid function, cortisol levels, and assess for SIADH from other medications 3
  4. Treatment approach: Depends on severity and symptoms:
    • Symptomatic/severe: Hypertonic saline (3% NaCl) as 100-150 mL IV bolus 7
    • Asymptomatic/mild: Fluid restriction (500 mL/day initially) with adequate solute intake 7

Important Caveats

While ACE inhibitors like ramipril are not among the most common causes of drug-induced hyponatremia (thiazides, SSRIs, antipsychotics, and antiepileptics are more frequent culprits) 2, 5, the association is well-documented and clinically significant when it occurs.

The combination of ramipril with thiazide diuretics creates a particularly high-risk scenario for hyponatremia development 1, 4. Guidelines recommend monitoring serum potassium frequently when these agents are combined, but sodium monitoring is equally critical 1.

Importantly, do not combine ramipril with ARBs or other ACE inhibitors, as this dual RAS blockade significantly increases the risk of renal dysfunction, hyperkalemia, and electrolyte abnormalities without providing additional cardiovascular benefit 8, 9, 1.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.